JL Molitor
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 4
- Vascular Tumors and Angiosarcomas 1
-
- Gastric Cancer Management and Outcomes 2
-
- Acute Myeloid Leukemia Research 1
-
- Genetic factors in colorectal cancer 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
- Co-authors
- Christophe LouvetAimery de GramontThierry AndréM KrulikÉlisabeth CarolaV. IzraëlJean‐Pierre LotzF. Maindrault-Gœbel
- Journals
- Annals of Oncology (1 paper)European Journal of Cancer (1 paper)La Revue de Médecine Interne (5 papers)
In The Last Decade
JL Molitor
9 papers receiving 411 citations
Peers
Comparison fields: 5 of 48
- Hepatology 115
- Oncology 357
- Pulmonary and Respiratory Medicine 120
- Hematology 40
- Pathology and Forensic Medicine 56
Countries citing papers authored by JL Molitor
This map shows the geographic impact of JL Molitor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Molitor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Molitor more than expected).
Fields of papers citing papers by JL Molitor
This network shows the impact of papers produced by JL Molitor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Molitor. The network helps show where JL Molitor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside JL Molitor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 19 | |
| 2 | 2004 | 9 | |
| 3 | 2000 | 101 | |
| 4 | 1999 | 235 | |
| 5 | 1997 | 11 | |
| 6 | Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer. | 1997 | 1 |
| 7 | 1997 | 33 | |
| 8 | 1997 | 10 | |
| 9 | [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]. | 1997 | 11 |
About JL Molitor
JL Molitor is a scholar working on Oncology, Hepatology, Hematology, Pathology and Forensic Medicine and Genetics, having authored 9 papers that have together received 430 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Genetic factors in colorectal cancer (2 papers), Gastric Cancer Management and Outcomes (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Acute Myeloid Leukemia Research (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Hepatology (115 citations), Oncology (357 citations), Pulmonary and Respiratory Medicine (120 citations), Hematology (40 citations) and Pathology and Forensic Medicine (56 citations). JL Molitor has collaborated with scholars based in France and Canada. Frequent co-authors include Christophe Louvet, Aimery de Gramont, Thierry André, M Krulik, Élisabeth Carola, V. Izraël, Jean‐Pierre Lotz, F. Maindrault-Gœbel, M. Luisa García and Pascal Artru. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, La Revue de Médecine Interne, Pathologie Biologie and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.